CN108137612A - 软性抗胆碱能药类似物的制剂 - Google Patents

软性抗胆碱能药类似物的制剂 Download PDF

Info

Publication number
CN108137612A
CN108137612A CN201680054285.4A CN201680054285A CN108137612A CN 108137612 A CN108137612 A CN 108137612A CN 201680054285 A CN201680054285 A CN 201680054285A CN 108137612 A CN108137612 A CN 108137612A
Authority
CN
China
Prior art keywords
composition
sweat
methyl
subject
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680054285.4A
Other languages
English (en)
Chinese (zh)
Inventor
N·S·博多尔
J·J·科伦
D·安古洛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bodor Laboratories Inc
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/805,114 external-priority patent/US20150320722A1/en
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Priority to CN202411185417.XA priority Critical patent/CN119033770A/zh
Priority to CN202411185418.4A priority patent/CN119033771A/zh
Priority to CN202411185422.0A priority patent/CN119033772A/zh
Publication of CN108137612A publication Critical patent/CN108137612A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201680054285.4A 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂 Pending CN108137612A (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202411185417.XA CN119033770A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185418.4A CN119033771A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185422.0A CN119033772A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/805,114 2015-07-21
US14/805,114 US20150320722A1 (en) 2014-03-13 2015-07-21 Formulation for soft anticholinergic analogs
PCT/US2016/043380 WO2017015485A1 (en) 2015-07-21 2016-07-21 Formulation for soft anticholinergic analogs

Related Child Applications (3)

Application Number Title Priority Date Filing Date
CN202411185418.4A Division CN119033771A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185422.0A Division CN119033772A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185417.XA Division CN119033770A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂

Publications (1)

Publication Number Publication Date
CN108137612A true CN108137612A (zh) 2018-06-08

Family

ID=57834721

Family Applications (4)

Application Number Title Priority Date Filing Date
CN201680054285.4A Pending CN108137612A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185418.4A Pending CN119033771A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185422.0A Pending CN119033772A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185417.XA Pending CN119033770A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂

Family Applications After (3)

Application Number Title Priority Date Filing Date
CN202411185418.4A Pending CN119033771A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185422.0A Pending CN119033772A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂
CN202411185417.XA Pending CN119033770A (zh) 2015-07-21 2016-07-21 软性抗胆碱能药类似物的制剂

Country Status (16)

Country Link
US (4) US20180228770A1 (enExample)
EP (1) EP3325487B1 (enExample)
JP (2) JP6647692B2 (enExample)
KR (3) KR102762010B1 (enExample)
CN (4) CN108137612A (enExample)
AU (1) AU2016297601B2 (enExample)
CA (2) CA2993602C (enExample)
ES (1) ES2881998T3 (enExample)
HK (1) HK1253236A1 (enExample)
HU (1) HUE055663T2 (enExample)
MX (1) MX386488B (enExample)
MY (1) MY185814A (enExample)
PH (1) PH12018500184A1 (enExample)
PL (1) PL3325487T3 (enExample)
WO (1) WO2017015485A1 (enExample)
ZA (1) ZA201800878B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114760997A (zh) * 2019-12-12 2022-07-15 全国皮肤中心 用于抑制身体异味的药物制剂
CN115175665A (zh) * 2020-03-03 2022-10-11 科研制药株式会社 含有索吡溴铵的药物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2836132T3 (es) 2013-08-08 2021-06-24 Novan Inc Composiciones tópicas y métodos de uso de las mismas
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
PL3325487T3 (pl) * 2015-07-21 2021-12-13 Bodor Laboratories, Inc. Preparat miękkich analogów przeciwcholinergicznych
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US20220401412A1 (en) * 2019-11-05 2022-12-22 Journey Medical Corporation Methods for palmar or plantar administration of pharmaceutical compositions
TW202146010A (zh) 2020-03-03 2021-12-16 日商科研製藥股份有限公司 原發性腋窩多汗症的治療方法及其醫藥
FR3124081B1 (fr) * 2021-06-21 2023-12-29 Oreal Composition cosmétique comprenant au moins une huile polaire, un polyol et au moins un actif hydrophile

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US20030054040A1 (en) * 1994-12-02 2003-03-20 Roser Bruce J. Solid dose delivery vehicle and methods of making same
WO2007059021A1 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic zwitterions
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
US20090208437A1 (en) * 2004-12-27 2009-08-20 Beiersdorf Ag Glycopyrrolate in cosmetic preparations
CN103784401A (zh) * 2012-10-29 2014-05-14 北京市丰硕维康技术开发有限责任公司 一种治疗呼吸道疾病的溶液型定量吸入气雾剂及制备方法
WO2014144075A1 (en) * 2013-03-15 2014-09-18 Bodor Laboratories, Inc. Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5143719A (en) * 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
CA2128063A1 (en) 1993-07-16 1995-01-17 Virgil A. G. Williams Stable, clear antiperspirant composition and method of use
US5895644A (en) * 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) * 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
WO2003026585A2 (en) 2001-09-26 2003-04-03 Lukacsko Alison B Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
AU2005265248A1 (en) * 2004-06-23 2006-01-26 Ortho-Mcneil Pharmaceutical, Inc. Methods for measuring chloride channel conductivity
US7087560B2 (en) 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
JP2007058971A (ja) 2005-08-24 2007-03-08 Alpine Electronics Inc 情報再生装置
US20080023423A1 (en) * 2006-07-31 2008-01-31 James Francis Duffy Device for Holding and Displaying Vial-shaped Beverage Containers
JP5371235B2 (ja) 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8618160B2 (en) 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
US20160166487A1 (en) 2013-07-30 2016-06-16 Glaxosmithkline Intellectual Property Development Limited Topical compositions for treatment of excessive sweating and methods of use thereof
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
PL3325487T3 (pl) 2015-07-21 2021-12-13 Bodor Laboratories, Inc. Preparat miękkich analogów przeciwcholinergicznych
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US20030054040A1 (en) * 1994-12-02 2003-03-20 Roser Bruce J. Solid dose delivery vehicle and methods of making same
US20090208437A1 (en) * 2004-12-27 2009-08-20 Beiersdorf Ag Glycopyrrolate in cosmetic preparations
WO2007059021A1 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic zwitterions
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
US7399861B2 (en) * 2005-11-10 2008-07-15 Bodor Nicholas S Soft anticholinergic esters
CN103784401A (zh) * 2012-10-29 2014-05-14 北京市丰硕维康技术开发有限责任公司 一种治疗呼吸道疾病的溶液型定量吸入气雾剂及制备方法
WO2014144075A1 (en) * 2013-03-15 2014-09-18 Bodor Laboratories, Inc. Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RAJ SAKAMURI: "ESTERS, ORGANIC", 《KIRK‐OTHMER ENCYCLOPEDIA OF CHEMICAL TECHNOLOGY》 *
颜耀东: "《缓释控释制剂的设计与开发》", 30 June 2006, 中国医药科技出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114760997A (zh) * 2019-12-12 2022-07-15 全国皮肤中心 用于抑制身体异味的药物制剂
CN115175665A (zh) * 2020-03-03 2022-10-11 科研制药株式会社 含有索吡溴铵的药物
CN115175665B (zh) * 2020-03-03 2024-04-16 科研制药株式会社 含有索吡溴铵的药物

Also Published As

Publication number Publication date
ZA201800878B (en) 2022-08-31
BR112018001262A2 (pt) 2018-09-11
KR102762010B1 (ko) 2025-02-05
PL3325487T3 (pl) 2021-12-13
JP6976594B2 (ja) 2021-12-08
CA2993602A1 (en) 2017-01-26
US20180228770A1 (en) 2018-08-16
MX2018000918A (es) 2018-08-15
HK1253236A1 (zh) 2019-06-14
KR20180030893A (ko) 2018-03-26
PH12018500184A1 (en) 2018-07-30
EP3325487A1 (en) 2018-05-30
CA3232529A1 (en) 2017-01-26
MY185814A (en) 2021-06-10
JP6647692B2 (ja) 2020-02-14
EP3325487A4 (en) 2019-03-20
JP2018520198A (ja) 2018-07-26
HK1251564A1 (zh) 2019-02-01
US11026919B2 (en) 2021-06-08
US20210077460A1 (en) 2021-03-18
EP3325487B1 (en) 2021-05-05
US10952990B2 (en) 2021-03-23
JP2020023588A (ja) 2020-02-13
US12357609B2 (en) 2025-07-15
ES2881998T3 (es) 2021-11-30
US20200121643A1 (en) 2020-04-23
WO2017015485A8 (en) 2018-02-15
KR20230151061A (ko) 2023-10-31
KR20250024093A (ko) 2025-02-18
AU2016297601B2 (en) 2021-08-19
CA2993602C (en) 2024-04-30
CN119033771A (zh) 2024-11-29
WO2017015485A1 (en) 2017-01-26
US20210228544A1 (en) 2021-07-29
MX386488B (es) 2025-03-19
CN119033770A (zh) 2024-11-29
CN119033772A (zh) 2024-11-29
AU2016297601A1 (en) 2018-02-15
HUE055663T2 (hu) 2021-12-28

Similar Documents

Publication Publication Date Title
US12398102B2 (en) Formulation for soft anticholinergic analogs
US12357609B2 (en) Formulation for soft anticholinergic analogs
US12156865B2 (en) Formulation for soft anticholinergic analogs
US20250295630A1 (en) Formulation for soft anticholinergic analogs
US20250346558A1 (en) Formulation for soft anticholinergic analogs
HK40096836A (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1253236

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180608